Published [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year]
Dr. Tyler Jacks, founding chairman of Skyhawk’s Scientific Advisory Board, receives the American Cancer Society’s top doubtless award, the Medal of Honor, first awarded in 1949, for his tireless dedication to addressing the complexities of cancer.
BOSTON, March 30, 2026 /PRNewswire/ — Skyhawk Therapeutics, Inc., a medical-stage biotechnology firm establishing novel shrimp molecule therapies to modulate serious RNA targets for a series of adverse diseases, broadcasts that the American Cancer Society (ACS) has awarded the 2026 Medal of Honor to Dr. Tyler Jacks, founding Chairman of Skyhawk’s Scientific Advisory Board, founding father of the David H. Koch Institute for Integrative Cancer Learn on the Massachusetts Institute of Expertise (MIT) and professor of biology at MIT. The Medal of Honor is the most prestigious award given by ACS to famous contributors who salvage made precious contributions in accepted, medical, translational, or population science and whose work has ended in pattern in cancer prevention, prognosis, remedy, or survivorship to toughen the lives of patients.
“Tyler Jacks is a if truth be told unheard of scientist and leader all over many fields and organizations. His recognition from ACS is richly deserved,” acknowledged Dr. Benjamin L. Ebert, MD, PhD, co-founding member of Skyhawk’s SAB and President and CEO of Dana-Farber Cancer Institute. “As founding Chairman of Skyhawk’s SAB, Tyler has been a deft recordsdata of the scientific programs at Skyhawk, addressing both cancers and other diseases with monumental unmet need for patients. We’re grateful for all of his prodigious contributions.”
“Tyler has labored for decades with creativity, ardour, talent and a blessed knack for collaboration to diminish the burden cancer and other horrifying diseases impose on patients and their families. I’m happy to search out his comely accomplishments as scientist and institution builder identified by the ACS, The usa’s most neatly-identified cancer institution,” acknowledged Skyhawk’s Co-founder and CEO Bill Haney. “Skyhawk’s pioneering work as a pace-setter in the RNA revolution has been transformed by Tyler’s insight—and I do know the list of other companies, non-earnings and universities who salvage likewise benefited from Tyler’s judgment and generosity of spirit is a long one.”
About Dr. Tyler Jacks
Dr. Jacks is a pioneer in the pattern and use of genetically engineered mouse units to glance complex-to-treat human cancers. These units lend a hand scientists know the map tumors originate and evolve, how carefully they resemble human cancers, and how instruments extinct in early cancer detection is prone to be improved. In his MIT lab, Dr. Jacks and his neighborhood glance how key genes, including tumor suppressors, oncogenes, and genes linked to DNA repair, lend a hand cancers withstand remedy and promote verbalize. Dr. Jacks has also conducted wide overview into how the immune machine sees and also fails to search out establishing cancers.
Creator of higher than 300 scientific papers, Dr. Jacks has served as chair of the Nationwide Cancer Advisory Board and the Board of Scientific Advisors of the Nationwide Cancer Institute and as previous president and board member of the American Affiliation of Cancer Learn (AACR). His many awards contain the AACR Prominent Success Award, the Paul Marks Prize for Cancer Learn, and MIT’s James R. Killian Jr. School Success Award. He is an elected member of the Nationwide Academy of Sciences and the Nationwide Academy of Medication.
Dr. Jacks graduated magna cum laude with top doubtless honors in biology from Harvard School. He earned his doctorate on the University of California, San Francisco, the put he studied below Dr. Harold Varmus, who won the 1989 Nobel Prize in Physiology or Medication for overview on oncogenes and cancer verbalize.
About Skyhawk Therapeutics
Skyhawk Therapeutics is a medical-stage biotechnology firm which makes use of its proprietary platform, SKYSTAR®, to understand and acquire shrimp molecule RNA modulating therapies for the area’s most intractable diseases. For more knowledge seek the recommendation of with, www.skyhawktx.com.
Skyhawk Contact
Maura McCarthy
Head of Corporate Trend
Leer long-established inform to download multimedia: https://www.prnewswire.com/news-releases/skyhawk-therapeutics-broadcasts-its-founding-scientific-advisory-board-chairman-receives-the-american-cancer-societys-2026-medal-of-honor-302728879.html
SOURCE Skyhawk Therapeutics
